Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02746471 · ClinicalTrials.gov registry record
Reveal LINQ Registry
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 1,604
- Enrollment target
NCT02746471: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT02746471 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,604 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02746471 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 1,604 participants
- Enrollment target
Study Summary
The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.
Primary Outcome
Clinical actions taken over the course of study follow-up
Interventions
- DEVICE Reveal LINQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,604 participants |
| Start Date | 2014-04 |
| Est. Completion | 2021-06-04 |
What the finished NCT02746471 record still lists
NCT02746471 is an observational study that tracks outcomes without assigning an intervention. Its 1,604 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Reveal LINQ is the first listed.
NCT02746471 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02746471 about?
NCT02746471 is a clinical study titled "Reveal LINQ Registry". The Reveal LINQ Registry will generate reliable long-term "real world" data of product performance, economic valuation, site-of-service procedural information.
What is the current status of trial NCT02746471?
This trial is currently completed. The enrollment target is 1,604 participants. The study started on 2014-04. Estimated completion is 2021-06-04.
What interventions are being tested in trial NCT02746471?
The interventions under investigation include: Reveal LINQ (DEVICE).
Who is sponsoring clinical trial NCT02746471?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia